Form 8-K - Current report:
SEC Accession No. 0001213900-18-014440
Filing Date
2018-10-25
Accepted
2018-10-25 08:20:23
Documents
2
Period of Report
2018-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k102418_wizepharmainc.htm 8-K 22221
2 PRESS RELEASE f8k102418ex99-1_wizepharma.htm EX-99.1 10710
  Complete submission text file 0001213900-18-014440.txt   34161
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 181137697
SIC: 2834 Pharmaceutical Preparations